|
| Status |
Public on Apr 16, 2024 |
| Title |
Unbiased profiling of clinical kinase inhibitors’ effects in activated macrophages using chromatin modifications as high-content readouts |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Dec 02, 2022 |
| Last update date |
Apr 17, 2024 |
| Contact name |
Francesco Gualdrini |
| E-mail(s) |
Francesco.gualdrini@ieo.it
|
| Organization name |
European Institute of Oncology
|
| Department |
Department of Experimental Oncology
|
| Lab |
Transcriptional Control in Inflammation and Cancer
|
| Street address |
Via Adamello, 16
|
| City |
Milan |
| ZIP/Postal code |
20139 |
| Country |
Italy |
| |
|
| Platforms (2) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (789)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE218966 |
Unbiased profiling of clinical kinase inhibitors’ effects in activated macrophages using chromatin modifications as high-content readouts [ATAC-Seq] |
| GSE218968 |
Unbiased profiling of clinical kinase inhibitors’ effects in activated macrophages using chromatin modifications as high-content readouts [Chromatin associated RNA-seq] |
| GSE219229 |
Unbiased profiling of clinical kinase inhibitors’ effects in activated macrophages using chromatin modifications as high-content readouts [RNA-Seq] |
| GSE219239 |
Unbiased profiling of clinical kinase inhibitors’ effects in activated macrophages using chromatin modifications as high-content readouts [ChIP-Seq] |
|
| Relations |
| BioProject |
PRJNA907787 |
Less...
More...